Duvic M - Search Results

1

Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients.

Emge DA, Bassett RL, Duvic M, Huen AO. Emge DA, et al. Among authors: duvic m. Arch Dermatol Res. 2020 May;312(4):283-288. doi: 10.1007/s00403-019-02015-7. Epub 2019 Nov 27. Arch Dermatol Res. 2020. PMID: 31776647

2

Cutaneous T-cell lymphoma in association with silicone breast implants.

Duvic M, Moore D, Menter A, Vonderheid EC. Duvic M, et al. J Am Acad Dermatol. 1995 Jun;32(6):939-42. doi: 10.1016/0190-9622(95)91328-9. J Am Acad Dermatol. 1995. PMID: 7751462

3

Photopheresis therapy for cutaneous T-cell lymphoma.

Duvic M, Hester JP, Lemak NA. Duvic M, et al. J Am Acad Dermatol. 1996 Oct;35(4):573-9. doi: 10.1016/s0190-9622(96)90683-0. J Am Acad Dermatol. 1996. PMID: 8859287

4

Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.

Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M. Jackow CM, et al. Among authors: duvic m. Blood. 1997 Jan 1;89(1):32-40. Blood. 1997. PMID: 8978274 Free article.

5

Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma.

Peterson SR, Talpur R, Duvic M. Peterson SR, et al. Among authors: duvic m. J Am Acad Dermatol. 1998 Sep;39(3):434-8. doi: 10.1016/s0190-9622(98)70320-2. J Am Acad Dermatol. 1998. PMID: 9738778

6

Enterococcal eschars in cutaneous T-cell lymphoma tumors: a distinct clinical entity.

Duvic M, Feasel AM, Schwartz CA, Cather JC. Duvic M, et al. Clin Lymphoma. 2000 Sep;1(2):141-5. doi: 10.3816/clm.2000.n.012. Clin Lymphoma. 2000. PMID: 11707823

7

Treatment of cutaneous T-cell lymphoma from a dermatologist's perspective.

Duvic M. Duvic M. Clin Lymphoma. 2000 Nov;1 Suppl 1:S15-20. doi: 10.3816/clm.2000.s.003. Clin Lymphoma. 2000. PMID: 11707858 Review.

8

Red nodule on the finger of an immunosuppressed woman.

Kandyil R, Maloney D, Tarrand J, Duvic M. Kandyil R, et al. Among authors: duvic m. Arch Dermatol. 2002 May;138(5):689-94. doi: 10.1001/archderm.138.5.689. Arch Dermatol. 2002. PMID: 12020236 No abstract available.

9

Therapy options in cutaneous T-cell lymphoma.

Apisarnthanarax N, Duvic M. Apisarnthanarax N, et al. Among authors: duvic m. Expert Rev Anticancer Ther. 2001 Oct;1(3):403-20. doi: 10.1586/14737140.1.3.403. Expert Rev Anticancer Ther. 2001. PMID: 12113107 Review.

10

Optimizing bexarotene therapy for cutaneous T-cell lymphoma.

Talpur R, Ward S, Apisarnthanarax N, Breuer-Mcham J, Duvic M. Talpur R, et al. Among authors: duvic m. J Am Acad Dermatol. 2002 Nov;47(5):672-84. doi: 10.1067/mjd.2002.124607. J Am Acad Dermatol. 2002. PMID: 12399758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters